Contact Us

Peter Chu, PhD

  • Published April 21, 2023
  • by Wayne Doyle

Share

Related articles

Person typing on a keyboard with bioinformatics images overlaid

eBlogs

01
14
25

AI-driven RNA drug development: a new era of discovery

Artificial intelligence is revolutionizing drug development, yet several challenges remain. In this eBlog we review the impact of AI-powered drug design for RNA-based and RNA-targeting therapies.

read more
Sign saying Review 2024

eBlogs

12
13
24

A look back at 2024: exciting advancements in RNA 

In this end-of-year eBlog, our team reflects on the successes of RNA research and drug development in 2024.

read more
Photo of the Eclipsebio team

eBlogs

11
14
24

2024 Thanksgiving Message from the CEO

Our CEO, Peter Chu, reflects on the successes of the past year and looks forward to 2025 in this Thanksgiving-themed eBlog.

read more
Cartoon schematic showing the different regions of an siRNA and how siRNAs can have off-target binding.

eBlogs

10
18
24

Reducing off-target effects in siRNA: expert tips for better efficacy

In this eBlog we discuss the mechanisms of siRNA off-target interactions and outlines strategies to minimize them.

read more